Press Release
Financial Institutions Being Held Accountable: Petroff Amshen LLP Advocates for Consumers Affected by Financial Mismanagement
Petroff Amshen LLP highlights the impact of a well-known big tech company and a major financial institution's deceptive practices, which have left thousands of victims with unauthorized charges and financial losses. With nearly two decades of experience, Petroff Amshen LLP is committed to holding corporations accountable and ensuring justice for those harmed by fraudulent bank activity. Read More
Press Release
New York City Nonprofit Bookkeeping Firm, Daily Balance, Expands With New NYC Location, Offering High-Quality Virtual Accounting for Local Nonprofits
Through its new NYC presence, Daily Balance empowers New York City nonprofits to cut administrative expenses by up to 40%, allowing them to prioritize their core mission and programs. Read More
Press Release
Electrovaya Reports Fiscal Year 2024 Results
Revenue of $44.6M with $4M Adjusted EBITDA1 (6th Consecutive Positive Quarter) Historic Positive Cash Flow from Operations and Improved Gross Margins Approval of $51million direct loan from The Export-Import Bank of the United States expected to fund Electrovaya's lithium ion cell and battery manufacturing facility in Jamestown, New York Removal of Going Concern note in the financial statements due to improved financial performance Read More
Press Release
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
The convergence of rising US healthcare costs, growing medical tourism, and the increasing demand for seamless patient financial experiences has created a perfect storm of opportunity for revenue cycle management software and outsourcing services vendors to expand their global presence and deliver transformative solutions Read More
Press Release
Dude Perfect Streaming Service Expands Content Offering and Welcomes the Hulett Brothers to an All-Star Lineup of Trusted Creators: Zach King, Ryan Trahan, and Mark Rober
The Safe Streaming™ powered service expands Totally Trusted Creator offering with trickshot duo, ensuring fans have access to top digital talent. Read More
Press Release
United Chargers Launches First-in-Industry Multi-App Capability for Its Popular Grizzl-E EV Charging Stations With Epic Charging
First time in the EV charging world, United Chargers is adding another software option to its popular Grizzl-E Ultimate and Grizzl-E Mini product line with Epic Charging. Now customers have a never-seen-before choice to select software that works better for their needs and ensures they're not stuck with just one software choice from the EVSE manufacturer. Read More
Press Release
Clinical Trial Supplies Global Market Forecast Report and Company Analysis 2025-2033, Profiles of Almac Group, Biocair, DHL, Thermo Fisher Scientific, Marken, Paraxel, Sharp Services, and PCI Pharma Services
Rising chronic disease incidence, tightening regulations, globalization of clinical trials, advances in biotechnology, introduction of biosimilars and orphan drugs, and newer technologies such as blockchain and IoT in supply chain management emerge as the key drivers for the Clinical Trial Supplies market Read More
Press Release
Introducing the Kind Mind Co.(TM): Introducing Accessible Art Tools for All Abilities
The Kind Mind Co.™ aims to bring accessibility back into the act of creativity, breaking down barriers for those with physical impairments or disabilities. The debut collection includes a range of tools with unique design elements—such as T-shaped grips, varied size multi-directional handles, extending tool holders and more. With adjustable positioning and straps, lightweight materials and CVI friendly-high visibility colors—every tool is crafted to expand access to making art. Read More
Press Release
Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTD The majority of patients in the OnTarget placebo group on abemaciclib and pertuzumab-based therapies required dose reduction or elimination Read More
Press Release
